YOGESH MAHADU KHETMALIS

Mr. YOGESH MAHADU KHETMALIS

Chemistry, Birla Institute of Technology and Science - Hyderabad Campus, Hyderabad, India
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YOGESH MAHADU KHETMALISYOGESH MAHADU KHETMALIS
YOGESH MAHADU KHETMALIS
AFAshna Fathima
Ashna Fathima
MSMarkus Schweipert
Markus Schweipert
CDCécile Debarnot
Cécile Debarnot
NBNaga Venkata Madhusudhan Rao Bandaru
Naga Venkata Madhusudhan Rao Bandaru
KSKondapalli Venkata Gowri Chandra Sekhar
Kondapalli Venkata Gowri Chandra Sekhar
A series of novel quinazoline-4-(3H)-one derivatives were designed and synthesized as histone deacetylase 6 (HDAC6) inhibitors based on novel quinazoline-4-(3H)-one as the cap group and benzhydroxamic acid as the linker and metal-binding group. A total of 19 novel quinazoline-4-(3H)-one analogues (5a–5s) were obtained. The structures of the target compounds were characterized using 1H-NMR, 13C-NMR, LC–MS, and elemental analyses. Characterized compounds were screened for inhibition against HDAC8 class I, HDAC4 class IIa, and HDAC6 class IIb. Among the compounds tested, 5b proved to be the most potent and selective inhibitor of HDAC6 with an IC50 value 150 nM. Some of these compounds showed potent antiproliferative activity in several tumor cell lines (HCT116, MCF7, and B16). Amongst all the compounds tested for their anticancer effect against cancer cell lines, 5c emerged to be most active against the MCF-7 line with an IC50 of 13.7 μM; it exhibited cell-cycle arrest in the G2 phase, as well as promoted apoptosis. Additionally, we noted a significant reduction in the colony-forming capability of cancer cells in the presence of 5c. At the intracellular level, selective inhibition of HDAC6 was enumerated by monitoring the acetylation of α-tubulin with a limited effect on acetyl-H3. Importantly, the obtained results suggested a potent effect of 5c at sub-micromolar concentrations as compared to the other molecules as HDAC6 inhibitors in vitro.

22 October 2025 in Journal of Pharmaceutical Innovation
Verified
Journal Article
Closed access
PDF file
RNRida Nongkhlaw
Rida Nongkhlaw
YOGESH MAHADU KHETMALISYOGESH MAHADU KHETMALIS
YOGESH MAHADU KHETMALIS
RNRidaphun Nongrum
Ridaphun Nongrum
JAJaganath Arunachalam
Jaganath Arunachalam
RNRishanlang Nongkhlaw
Rishanlang Nongkhlaw